Could we…and would we..? UK CoA confirms that it is bound by previous precedent on second medical use SPCs
Life Sciences analysis: The UK Court of Appeal (CoA) handed down its decision in the much-awaited Merck Serono v Comptroller-General of Patents case on 28 January 2025. Not only did the three-judge bench of LJs Lewison, Arnold and Birss confirm that the court could not deviate from previous binding (UK) precedent on second medical use Supplementary Protection Certificates (SPCs), the court also noted that even if it could deviate from its own previous case law, it would not choose to do so in this case. Priyanka Madan, senior associate and specialist in SPC and pharmaceutical regulatory issues at Herbert Smith Freehills LLP, discusses the judgment.